EOG Resources Inc (EOG) Stock Price Today
Aura AI Summary
Key Stats
- $73.22BMarket Cap
- -Volume
- EnergySector
- $149.8952W High
- $101.7852W Low
- -Typical Hold Time
- $77.68BEnterprise Value
- 2.97%Div Yield
- -Trading Activity
Track EOG Resources Inc (EOG) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, EOG Resources Inc has traded between a low of $101.78 and a high of $149.89, highlighting its annual price range. Buy and sell EOG Resources Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Most Recent News
Aduro and ECOCE complete Phase 1 of mapping flexible plastic waste in Mexico, starting HCT testing for circular recycling.
Aduro Clean Technologies and ECOCE have successfully completed Phase 1 of mapping flexible and multilayer plastic waste streams in Mexico, estimated at 1.5 million tons annually. The project now moves into testing these materials using Aduro's Hydroc...

Aduro and ECOCE advance to HCT testing for recycling Mexico's flexible plastic waste streams.
Aduro Clean Technologies and ECOCE have completed phase 1 of mapping flexible plastic waste streams in Mexico, estimated at 1.5 million tonnes annually. They are now moving selected post-consumer flexible packaging materials into Hydrochemolytic™ (HC...

FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patients
The FDA has granted traditional approval to Fabhalta (iptacopan), a first-in-class complement inhibitor, for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN). Fabhalta showed a 48% slower decline in kidney fu...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.